期刊文献+

腹腔镜下巨大子宫肌瘤切除术中出血量增多因素探讨 被引量:19

Factors of increased bleeding amount during laparoscopic huge hysteromyomectomy
下载PDF
导出
摘要 目的探讨腹腔镜下巨大子宫肌瘤切除术中出血量增多的因素。方法将76例巨大子宫肌瘤患者分为超大肌瘤组(A组)、多发肌瘤组(B组)、伴子宫腺肌病组(C组)以及单纯巨大肌瘤组(D组)4组,观察并对比4组手术时间、术中出血量、住院时间及并发症。结果 A、B、C 3组手术时间、术中出血量明显大于D组(P<0.05),A、B、C 3组之间手术时间、术中出血量无显著差异,4组住院时间及并发症无显著差异。结论腹腔镜下巨大子宫肌瘤切除术中出血量增多与肌瘤的体积、数目,以及是否伴有子宫腺肌病具有密切关系,术前对这些情况进行评估并采取相应措施,对减少术中出血具有重要意义。 Objective To explore the factors of increased bleeding amount during laparoscopic huge hysteromyomectomy.Methods Seventy-six patients with huge uterine fibroids were divided into extra large fibroids group(group A),multiple fibroids group(group B),adenomyosis group(group C) and simple huge fibroids group(group D).The operation time,bleeding amount,length of stay and complications among the four groups were compared.Results The operation time and bleeding amount in groups A,B,C were obviously higher than those in group D(P〈0.05).The operation time and bleeding amount among groups A,B and C showed no obvious difference.The length of stay and complications among the four groups had no obvious difference.Conclusion The increased bleeding amount during laparoscopic huge hysteromyomectomy is closely related to the volume,number of fibroids and accompanied adenomyosis.It is important to assess these conditions before surgery in order to reduce bleeding in operation.
出处 《实用临床医药杂志》 CAS 2012年第3期80-81,84,共3页 Journal of Clinical Medicine in Practice
关键词 腹腔镜 巨大子宫肌瘤 出血 laparoscopic; huge uterine fibroids; bleeding;
  • 相关文献

参考文献14

二级参考文献62

共引文献59

同被引文献127

  • 1徐焕,华克勤,蒋红元.腹腔镜手术治疗子宫后壁肌瘤28例临床分析[J].复旦学报(医学版),2007,34(6):908-910. 被引量:2
  • 2冯怡辰,马彩铃.腹腔镜下子宫肌瘤剔除术新进展[J].中国全科医学,2009,12(9):820-822. 被引量:38
  • 3丰有吉,沈铿.妇产科学[M].北京:人民卫生出版社,2011:73-74.
  • 4Ligon AH, Morton CC. Leiomyomata: Heritability and cytogenetic studies[J]. Hum Reprod Update, 2001, 7: 8.
  • 5Sarhadi VK, Wikman H, Satmankivi K, et al. Increased expression of high mobility group A proteins in lung cancer[J]. J Pathok, 2006, 209(2): 206.
  • 6Beige G. Meyer A, Klemke M. et al. Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias [J]. Genes Chromosomes Cancer, 2008. 47(1): 56.
  • 7Malek A. Bakhidze E. Noske A, et al. HMGA2 gene is a promising target for ovarian cancer silencing therapy[J]. Int J Cancer, 2008. 123(2): 348.
  • 8Bustin M, Reeves R. High - mobility - group chromosomal proteins: architectural components that facilitate chromatin function[J]. Prog Nueleic Acid Res Mol Bioi, 1996, 54: 35.
  • 9Gianini G. Marcotullio L D, Ristori E, et al. HMGI(Y) and HMGI - C Genes Are Expressed in Neuroblastoma Cell Lines and Tumors and Affect Retinoic Acid Responsiveness [J ]. Cancer Res. 1999, 59(10): 2484.
  • 10HOCKR. FURUSAWAT. UEDAT. et al. HMGchromosomal proteins in development and disease[J]. Trends Cell BioI. 2007,17(2): 72.

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部